Becky Schweighardt, PhD is the Chief Scientific Officer and Chief Operating Officer at Grace Science, LLC. She is an experienced translational scientist dedicated toward developing life-changing treatments for rare diseases. Her experience reaches across all stages of development from discovery to post-marketing and across multiple drug modalities, including gene therapies, protein therapeutics, oligo nucleotides, and small molecules. She has 25+ years of academic and industry experience, including 10 years developing therapeutics for rare disease at BioMarin Pharmaceutical prior to joining Grace Science in 2020.